CAMPAIGN PRIORITY: Precision Medicine

Doylestown Health is proud of our long history of innovative, compassionate care. Coupled with a uniquely human approach, each and every patient is treated as an individual. Precision medicine—also known as personalized medicine—encompasses our forward-thinking care model.

According to the National Institutes of Health (NIH), precision medicine is “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.” The goal of precision medicine is to design a treatment strategy based on each patient’s unique genetic profile, in order to yield more effective treatments and better outcomes. Instead of the traditional “one size fits all” approach, in which all patients with the same diagnosis receive the same treatment, Doylestown Health’s clinical team applies targeted therapies based on unique genetic profiles resulting in better outcomes.

Your investment will support the acquisition of state-of-the-art technology that can determine the sequence of patients’ DNA or RNA, and study genetic variations associated with diseases. Hosting this technology in-house will reduce the time from biopsy to diagnosis by more than 50 percent, allowing patients to begin treatment—and healing—faster.